Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Poxel SA

POXEL.PA ✓ COMPLIANT ☆ Track — members

Euronext Paris · Healthcare · Biotechnology & Medical Research ·

France Micro Cap Analyst: N/A

Last Close

$0.23

▲ +0.50%

Market Cap $12.55M · Vol 498.66K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$12.55M

Micro Cap

Div Yield

N/A

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

52.40

Momentum

Beta

1.10

vs Market

52W High

$0.56

58.81% below

52W Low

$0.22

5.70% above

Volume

498.66K

Avg 147.23K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

94.27%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Poxel SA (POXEL.PA) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does POXEL.PA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-0.74%

+0.75%

-19.64%

-30.17%

YTD

-13.46%

-33.82%

-63.27%

-96.50%

Financials & Valuation

TTM · Annual

Total Revenue	$5.89M
Net Income	N/A
Revenue Growth (YoY)	-48.32%
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	N/A · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	53.76M

Technical Indicators

50-Day SMA	$0.24
200-Day SMA	$0.28
RSI (14)	52.40
Beta	1.10
52-Week High	$0.56
52-Week Low	$0.22

Volume Today	498.66K
Avg Daily Volume (30D)	147.23K
Relative Volume	3.39x
Volatility (10D)	31.10
Volatility (30D)	24.95
Free Float	94.27%

Analyst Consensus

N/A

Current Price $0.23

Mean Target N/A

52W Low$0.22 52W High$0.56

Current

Target

$0.22 $0.56

Current Analyst target

· 0 analysts

Identifiers

ExchangeEuronext Paris

FIGIBBG001V0GP18

ISINFR0012432516

CountryFrance

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd -2.85% ARGX.BR argenx SE -3.21% ARGX argenx SE -0.66% INSM Insmed Inc -2.05% 2269.HK WuXi Biologics (Cayman) Inc -1.27%

Company Profile

Poxel SAS is a France-based company principally engaged in the biopharmaceutical sector. The Company develops drugs with a focus on Type 2 diabetes. The Company aims at developing drugs from preclinical to phase 2 clinical proof of concept. Its lead product, Imeglimin, is in clinical phase 2 study for Type 2 diabetes indication. A direct activator of AMPK for the treatment of Type 2 diabetes has started its preclinical development, and other projects in the research phase target diabetes and other metabolic diseases with small molecules that have a disease-modifying mechanism of action. Poxel SAS was spun out from Merck Serono. The Company cooperates with the Laboratory for Fundamental and Applied Bioenergetics, Sumitomo Dainippon Pharma, Joseph Fourier University and Department of Cell Physiology and Metabolism at the University of Geneva, Switzerland, among others.